LINC01162: A Long Intergenic Non-Protein Coding RNA (G104355138)

Target Name: LINC01162

NCBI ID: G104355138

LINC01162

Other Name(s): long intergenic non-protein coding RNA 1162 | Long intergenic non-protein coding RNA 1162

LINC01162: A Long Intergenic Non-Protein Coding RNA

Introduction

LINC01162 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its ability to interact with proteins and other non-protein molecules, making it a potential drug target or biomarker.

Expression and Localization

LINC01162 is expressed in various tissues and organs, including the brain, heart, and gastrointestinal tract. It is primarily localized to the cytoplasm of cells and can be detected in the endoplasmic reticulum (ER) and the nuclear pellets.

Function and Interaction

LINC01162 is involved in various cellular processes, including cell adhesion, migration, and transcriptional regulation. It has been shown to interact with various proteins, including the transcription factor, NF-kappa-B, and the protein kinase, p300. These interactions may contribute to the regulation of cellular processes and the development of certain diseases.

Drug Interaction

LINC01162 has been identified as a potential drug target due to its involvement in various cellular processes that can be targeted by small molecules. For example, LINC01162 has been shown to be regulated by the transcription factor, SMY/TAZ, which is a known drug target for various diseases, including cancer.

Additionally, LINC01162 has been shown to be regulated by the protein kinase, p300. p300 is a known drug target for various diseases, including Alzheimer's disease and Parkinson's disease.

Biomarker

LINC01162 may also be used as a biomarker for various diseases, including cancer. Its ability to interact with proteins and other non-protein molecules makes it a potential target for small molecules that can be used to diagnose and treat cancer.

Conclusion

LINC01162 is a long non-coding RNA that has been identified in various organisms and has been shown to interact with proteins and other non-protein molecules. Its functions and interactions make it a potential drug target or biomarker for various diseases. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 1162

The "LINC01162 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01162 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets